
Citibrisk 500mg Tablet
Marketer
Starus Pharmaceuticals
Salt Composition
Citicoline (500mg)
Overview Citibrisk 500mg Tablet
Neurogard 500mg tablets are indicated for managing stroke, traumatic brain injury, Alzheimer's disease, and dementia associated with Parkinson's disease. This medication safeguards brain neurons from harm and facilitates their repair. Neurogard 500mg may be administered with or without food; however, consistent daily timing is recommended for optimal therapeutic levels. Dosage is individualized based on age and underlying condition, strictly following your physician's instructions regarding frequency and duration. Abrupt cessation is discouraged; consult your doctor before discontinuing treatment to avoid symptom exacerbation. Potential side effects, such as hypotension, abdominal discomfort, diarrhea, cardiac arrhythmias, skin rashes, sleep disturbances, and worsening paresthesia in affected limbs, are generally transient and self-limiting. Persistent or bothersome side effects necessitate medical consultation. Prior to commencing treatment, disclose any history of renal impairment, seizures, or epilepsy. Comprehensive medication disclosure to your physician is essential before starting Neurogard 500mg. Further, inform your doctor of pregnancy, pregnancy planning, or breastfeeding.
Uses of Citibrisk 500mg Tablet
Managing Stroke|Head Injury Care|Alzheimer's Disease Management|Dementia Treatment in Parkinson's
Major Benefits of Citibrisk 500mg Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Citibrisk 500mg Tablets can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Citibrisk 500mg Tablet:
- Decreased blood pressure
- Arrhythmia (irregular heartbeats)
- Stomach pain
- Diarrhea
- Insomnia (difficulty in sleeping)
- Rash
- Peripheral neuropathy (tingling and numbness of feet and hand)
How to use Citibrisk 500mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Citibrisk 500mg Tablets can be consumed with or without food, though consistent timing is recommended.
How Citibrisk 500mg Tablet works:
Neurogard 500mg tablets offer neuroprotective action. This medication supports nerve cell health, shielding them from injury and enhancing their viability through the production of key neurochemicals such as phosphatidylcholine and acetylcholine. Furthermore, it mitigates the accumulation of free fatty acids at nerve injury sites.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction of alcohol with Citibrisk 500mg Tablet is undetermined. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Data on the use of 500mg Citibrisk tablets in pregnancy are absent. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the safety of 500mg Citibrisk tablets while breastfeeding is lacking. Seek medical advice from your physician.
DrivingCONSULT YOUR DOCTOR
The effect of Citibrisk 500mg Tablet on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyCAUTION
Renal impairment necessitates careful administration of Citibrisk 500mg tablets; dosage modification may be required. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Data regarding the administration of 500mg Citibrisk tablets to individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Citibrisk 500mg Tablet :
Should you forget a Citibrisk 500mg Tablet dose, take it immediately. But if your next dose is nearly due, omit the missed dose and resume your usual schedule. Never take a double dose.
Facts to Know About Citibrisk 500mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Ribonucleoside diphosphate pyrimidine |
| Developing Habits | No. |
| Treatment Category | Central Nervous System (CNS) Neurology |
| Action class | Cognitive enhancer |
